Background {#Sec1}
==========

Animal diseases are estimated to reduce the production of animal products by at least 20% according to the World Organisation for Animal Health (OIE) \[[@CR1]\]. As such, the prevention and control of animal diseases has benefits in terms of animal health and welfare but also human health where zoonoses are concerned and broad societal benefits in terms of companion animal health and the security of a safe food supply.

In terms of funding, it is estimated that the public sector spends €400 million per year in Europe on animal health and welfare related research \[[@CR2], [@CR3]\] and the private sector spends €400 million per year on animal health research \[[@CR4]\]. With about €800 million being spent per year, the added value of an objective process to prioritise critical research can be appreciated. By focusing a proportion of this expenditure on critical gaps in priority diseases, it will be possible to speed up the development and delivery of new and improved disease control tools including diagnostics, vaccines and pharmaceuticals to reduce the burden of disease on animals. Given that the current value of animal based products at producer prices in the E.U. is €154 billion per year \[[@CR5]\], every percentage reduction in the impact of animal disease on production would be of major economic importance.

During the work of the European Technology Platform for Global Animal Health (ETPGAH)[1](#Fn1){ref-type="fn"} from 2004 to 2012, it was recognised that disease prioritisation was one of the most important initiatives that needed to be undertaken to focus and prioritise research \[[@CR6]\]. This work necessitates the identification of gaps in knowledge as well as control tools -- diagnostics, vaccines and pharmaceuticals.

The DISCONTOOLS project was funded under the EU 7th framework programme from 2008 to 2013 and originated from the Action Plan of the ETPGAH. The general objective of the project was to evaluate global animal health priorities and the risk they could pose to the European Union. This understanding would assist in ensuring the most effective allocation of research funding. The project led to the development of a disease database containing a gap analysis and prioritisation model for 52 infectious diseases of animals. The objective of this paper is to describe the different steps in the development of the database (Section [Construction and content](#Sec2){ref-type="sec"}), describe its utility (Section [Utility](#Sec11){ref-type="sec"}) and discuss how it could assist policy makers in targeting research funding (Section [Discussion](#Sec14){ref-type="sec"}). It should be noted that the focus of the database is on research needs with respect to control tools in the form of diagnostics, vaccines and pharmaceuticals. It does not necessarily consider disease control strategies or other aspects of disease control such as disease modelling, surveillance and regulatory support.

Methods {#Sec2}
=======

General approach {#Sec3}
----------------

The DISCONTOOLS project was organised as shown in Fig. [1](#Fig1){ref-type="fig"}. All European and Global organisations with an interest in animal health research were invited to join the Stakeholder Forum. It included organisations ranging from farmers, veterinarians and the pharmaceutical industry to chief veterinary officers, research institutes and related projects funded by the European Commission. The Project Management Board (PMB) comprised 10 representatives from the Stakeholders selected to represent research, industry, users and public bodies. The membership is listed in Table [1](#Tab1){ref-type="table"}.Fig. 1Organisation of the DISCONTOOLS project Table 1Organisations represented in the Project Management Board of DISCONTOOLSOrganisationDescriptionCopa-CogecaEuropean union for agricultural organisations and cooperativesCVO'sChief Veterinary OfficersDG ResearchDirectorate-General for Research and Innovation of the European CommissionEAEVEEuropean Association of Establishments for Veterinary EducationEMIDA ERA-netCoordination platform of research on emerging infectious diseases of animalsEMVDEuropean Manufacturers of Veterinary DiagnosticsEPIZONEInternational network of veterinary research institutes working on epizootic animal diseasesFVEFederation of Veterinarians of EuropeHMAHeads of Medicines AgenciesIFAH-EuropeInternational Federation for Animal Health EuropeMEDVETNETEuropean Network of Excellence for Zoonoses ResearchOIEWorld organisation for animal health

Five work packages or working groups were established each reporting to the PMB. Of these two working groups one on disease prioritisation, the other on gap analysis were involved in developing the database (See Fig. [1](#Fig1){ref-type="fig"}). Membership of the two working groups consisted of approximately 15 people and was by invitation along with nominations from the stakeholders and interested parties. It was important that each of the groups was balanced with members with appropriate expertise from research, industry, users (including farming and veterinary profession) and regulators as well as the European Commission and international organisations.

The development of the database was preceded by a review of existing processes for prioritisation and gap analysis by the PMB in order to steer the methodology adopted. Subsequently, the disease list was selected and prioritisation methodology developed, followed by expert opinion elicitation to provide content to the database. The prioritisation methodology was subdivided in the development of Disease & Product analysis document (D&P), a prioritisation model and gap analysis model.

Review of existing prioritisation models {#Sec4}
----------------------------------------

A worldwide review of existing models was carried out. In public health, a number of studies have methodically prioritised communicable diseases and pathogens \[[@CR7]--[@CR15]\]. In the field of animal health, most studies have focused on prioritisation of food-borne and zoonotic pathogens \[[@CR13], [@CR16]--[@CR20]\]. In addition, studies have also been conducted with the specific aims of prioritising surveillance of wildlife pathogens \[[@CR21]\], disease control for poverty alleviation \[[@CR22]\], non-regulatory animal health issues \[[@CR23]\] and exotic diseases and emerging animal health threats \[[@CR24], [@CR25]\].

Although methodological approaches differ, priority-setting studies typically follow a series of steps: (i) selecting a group of diseases/pathogens for prioritization; (ii) identifying a list of appropriate and measurable criteria to assess diseases/pathogens; (iii) defining a range of levels for each criterion; (iv) determining the relative importance by means of a weight or score for each level and criterion; (v) aggregating to produce an overall score for each disease/pathogen; and (vi) ranking diseases/pathogens by their overall score to derive a recommended list for prioritization \[[@CR26]\]. It was evident that risk-based priority-setting should be systematic, flexible, reproducible and informative to public policy. The criteria must be explicit, measurable, relevant and objective wherever possible. However, the methodology and criteria required will depend on the goal of prioritisation, so a clear definition of the aim is essential. The priority-setting process should be transparent and open to discussion and revision. In addition, it is considered preferable to define a disease as specifically as possible (e.g. brucellosis of cattle versus brucellosis in general) and to consider how the model can evolve over time in order to remain of value. On the basis of the review, and considering the goal of DISCONTOOLS, i.e. identifying research needs of infectious animal diseases in the EU, the main steps which have been followed include establishing a list of relevant infectious diseases and gathering relevant information on each disease. It was considered essential that the scoring system allows diseases to be ranked based on total scores and/or on scores for particular criteria (e.g. impact on public health).

Establishment of disease list {#Sec5}
-----------------------------

The working groups of the DISCONTOOLS project were created by inviting stakeholders to become involved in WP2, WP3 and/or WP4 with the PMB taking care of WP1 and WP5 (see Fig. [1](#Fig1){ref-type="fig"}). In parallel, the PMB invited an expert to Chair each of WP2, WP3 and WP4. The WPs then established a list of 52 priority diseases to be included in the prioritisation exercise. The starting point for the list of diseases was from the Action Plan of the ETPGAH which referred to 47 diseases. In addition, it was considered important not to lose sight of endemic diseases or disease syndromes (e.g. internal parasites, mastitis). Therefore, 3 groups of diseases were defined as follows:epizootic diseases: infectious diseases which pose a risk for introduction or spread in the EU and for which tools for optimum detection, surveillance and control would be beneficial;food producing animal complexes: major enzootic diseases of livestock in Europe;zoonotic diseases: infectious diseases of animals that are important for human health and for their socio-economic effects.

The geographic dimension of the project was primarily European. Naturally, where a disease was not present in Europe, a global perspective was taken into account. The expert groups were asked to highlight and take into account strains and species where the economic impact was the highest not only in Europe, but worldwide.

After discussions of the working groups of DISCONTOOLS a final list of 52 diseases was agreed. The list was not considered to be exhaustive, but representative of most disease scenarios. Infectious diseases of aquatic animals or companion animals without a zoonotic implication were not considered.

Results {#Sec6}
=======

Prioritisation methodology {#Sec7}
--------------------------

### Disease and product analysis document {#Sec8}

A D&P was developed for each disease by the working groups of the DISCONTOOLS project in order to have key information available prior to scoring of the different criteria. The D&P is a reference document that provides the detailed and relevant information for each disease which is necessary to support the scoring for the prioritisation and gap analysis models. It contains 23 main sections with sub-headings covering a wide range of aspects such as description and characteristics of the disease, route of transmission, zoonotic potential, control tools available, and socio-economic impact. The full list of sections may be consulted at [www.discontools.eu/diseases](http://www.discontools.eu/diseases) under the custom report section. For each section, an additional column headed "Gaps identified" was included in the D&P to gather further information on the gaps in knowledge and products of each disease. The document was completed by the expert groups who were asked to reach a consensus on the final text which was then reviewed by the PMB.

### Prioritisation model {#Sec9}

The criteria, levels within each of the criteria, scores and weighting coefficients that were used in the prioritisation model can be viewed in Table [2](#Tab2){ref-type="table"}. Six criteria were considered:disease knowledgeimpact on animal health and welfareimpact on public healthimpact on wider societyimpact on tradecontrol tools Table 2The prioritisation model: criteria considered, levels within the criteria, scores and applied weighting coefficients (Coef)CriteriaScoresCoefTotal (score\*coef)Disease knowledge012342.5/100 1. Speed of spread 2. Number of species involved 3. Persistence of infectious agent in the environment 4. Risk of spread to susceptible populations 5. Potential for silent spread 6. Wildlife reservoir and potential spread 7. Vector reservoir and potential spread 8. Variability of the agent 9. Understanding of fundamental immunology 10. Host pathogen interactionImpact on animal health and welfare012348.33/100 1. Disease impact on production 2. Duration of animal welfare impact 3. Proportion of animals affected and suffering pain/injury/distress as a result of the diseaseImpact on public health -- human health012344.16/100 1. Impact of occurrence on human health 2. Likelihood of occurrence 3. Impact of occurrence on food safety 4. Transmissibility (spread from animals to humans) 5. Spread in humans 6. Bioterrorism potentialImpact on wider society012348.33/100 1. Economic direct impact (including cumulative cost, e.g. enzootic vs. epizootic) 2. Economic indirect impact (social, market) 3. Agriterrorism potentialImpact on trade012346.25/100 1. Impact on international trade due to existing regulations 2. Impact on EC trade due to existing regulations 3. Potential for regionalisation 4. Impact on security of food supplyControl tools+2+10−1−216.66/100 1. Appropriate diagnostics 2. Appropriate vaccines 3. Appropriate pharmaceuticalsTotal Score

An interpretation guide (<http://www.discontools.eu/upl/1/default/doc/1233_PrioInterV3-1-20110303.pdf>) was developed to help the expert groups decide on the appropriate scores to apply to each criterion. The expert groups were asked to reach a consensus for the scoring of each criterion. A 5 -- tiered scoring system was chosen as this appeared to offer a greater flexibility across the various criteria. The scoring scale applied to the 5-tiered system is as follows: for the first five sections 0, +1; +2; +3; +4 are used; for the sixth section dealing with control tool scores of +2; +1; 0; −1; −2 are used. This scoring scale was selected to highlight the differences in control tools for each disease in the sense that if for a particular disease a vaccine exists that has a high level of efficacy, quality, safety and availability, then a negative score will be attributed to the final total score of the concerned disease to diminish its priority as an effective tool is available. On the contrary, if control tools are missing, then a positive score will be added to the total score meaning that the disease will be higher in the prioritised list of diseases.

The weighting coefficient for each level of a criterion was computed as follows:$$\documentclass[12pt]{minimal}
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                \begin{document}$$ W = \frac{100}{X*I} $$\end{document}$$where *W* = the weighting coefficient, *X* is the maximum score of a level within a criterion and *I* is the number of levels within a criterion. This ensured that the maximum score of each criterion was 100 and that the different criteria were attributed the same weight in the overall score.

As there are 6 criteria for each disease, the scores could be grouped, listed, ranked or presented in a wide range of ways using either the overall score or the individual scores for each criteria.

### Gap analysis model of control tools {#Sec10}

The criteria, levels within each of the criteria, scores and weighting coefficients that were used in the gap analysis model can be viewed in Table [3](#Tab3){ref-type="table"}. Gap analysis considered 3 areas: diagnostic, vaccine and pharmaceutical gaps. The scoring system goes from +2 (important gap) to −2 (current tools are appropriate and no need to focus research in this area). As with the prioritisation model, an interpretation guide was developed to facilitate consistency in scoring (<http://www.discontools.eu/upl/1/default/doc/1235_GapAna-Inter-V3-1.pdf>).Table 3The gap analysis model: criteria considered, levels within the criteria, scores and applied weighting coefficients (Coef)CriteriaScoresCoefTotal (score\*coef)Diagnostic tools210−1−24.17/100 1. Availability^a^ 2. Prevention and control - Differentiation of infected from vaccinated (DIVA) 3. Strategic reserve 4. Capacity of production 5. Market potential 6. Affordable 7. Quality/stability durability 8. Sensitivity 9. Specificity 10. Reproducibility 11. Simplicity/ease of use 12. SpeedVaccination tools210−1−24.55/100 1. Commercial availability^a^ 2. Monitoring for infection in a vaccinated population 3. Strategic reserve 4. Capacity of production 5. Market potential 6. Affordable 7. Quality/stability 8. Safety of vaccines 9. Efficacy 10. Immunity 11. Convenience of usePharmaceutical tools210−1−24.55/100 1. Availability^a^ 2. Prevention and control 3. Strategic reserve 4. Capacity of production 5. Market potential 6. Cost 7. Quality 8. Safety animal 9. Safety consumer/user concerns 10. Safety environment 11. ResistanceTotal Score:^a^A maximum score of 20 was given to the whole criterion when there isn't any product available (not even under development)

Expert opinion elicitation {#Sec11}
--------------------------

An expert group leader was appointed for each disease and was asked to engage other experts. Where possible each group was asked to include experts with laboratory and diagnostic expertise, an epidemiologist, an industry representative and an individual with economic/trade expertise. The leader was expected to organise a physical or e-meeting in order to provide the information as described below. The names of the experts are published on the DISCONTOOLS website.

The average number of experts per group was 7. For 43 of the 52 included diseases (83%) the expert groups involved at least 4 members considered to cover the requested expertise (diagnostic, epidemiology, industry, economics). However for 9 diseases (17%), ≤3 experts were included (i.e. contagious bovine pleuropneumonia, swine influenza virus, peste des petits ruminants, rift valley fever, liver fluke, bovine herpes virus type 1, leptospirosis, salmonella, Crimean congo haemorrhagic fever).

Utility {#Sec12}
=======

DISCONTOOLS website {#Sec13}
-------------------

The DISCONTOOLS website contains two main sections: (i) work group pages and (ii) the disease database. The work group pages contain relevant minutes, documents and presentations related to meetings of the project management board.

The disease database contains the full D&P, along with a 2-page summary to make it easy to interpret the outcome. All the available information can be filtered for specific diseases or specific sections of the analysis and the customized reports can be downloaded in.pdf or.xls format. There is also a tool to enable web site users to provide comments on the D&P to the DISCONTOOLS secretariat. The prioritisation model and gap analysis model can be consulted for one or more diseases simultaneously and the specific scores for individual levels of criteria can be consulted or downloaded through custom reports.

Ranking of diseases by prioritisation model, disease category and gap analysis model {#Sec14}
------------------------------------------------------------------------------------

In Table [4](#Tab4){ref-type="table"}, diseases are ranked based on the total score of the prioritisation model. The Table is very useful in terms of providing a 'Big Picture' view and shows that the top ranked diseases comprise mostly zoonotic diseases and epizootic (often exotic) diseases. This, in turn, helps to guide funders who are working in an international environment and with a broad remit in terms of priorities. In Table [5](#Tab5){ref-type="table"}, the diseases were ranked within disease category. This provides an opportunity to identify priorities within different research domains. As such, funders with an interest in public health will look to the zoonoses ranking. In contrast, funders focusing on international trade will have a great interest in the epizootic diseases ranking and funders who are focusing on the efficiency of production, especially within individual countries, will have a great interest in the ranking of food producing animal complexes. The results of the gap analysis model can be used to obtain more details of the gaps in control tools. As an example, in Table [6](#Tab6){ref-type="table"} we provide the scores of the gap analysis model for diagnostics, vaccines and pharmaceuticals for the top 10 ranked diseases within each disease category. In general, this table highlights the major gap in pharmaceuticals for the epizootic diseases which is not surprising as the availability of antivirals for the majority of diseases is very limited or non-existent at present. In contrast, for the food producing animal complexes, the picture is more diverse with, dependent on the disease, remaining gaps in diagnostics and vaccines and less so in pharmaceutical development. For the zoonotic diseases, good diagnostics are generally available and the analysis highlights the need for research into vaccine development. It should be noted that, whilst the gap is identified, in many cases, it is unlikely that a pharmaceutical solution would be pursued, for example Bluetongue.Table 4Ranking of 52 infectious diseases of animals by the overall score of the prioritisation modelDiseaseOverall scoreNipah virus464Peste des petits ruminants385African swine fever373Rift valley fever365Bovine tuberculosis359Foot and mouth disease310Non tse-tse transmitted animal trypanosomiasis296African horse sickness294Cryptosporidiosis291Salmonellosis282Contagious bovine pleuropneumonia269Leishmaniosis262Brucellosis254Leptospirosis250Classical swine fever247Lumpy skin disease244Bluetongue241Orthopox237Hepatitis E virus237Poultry coccidiosis226Paratuberculosis223Anthrax220Campylobacter219Sheep and goat pox virus218Q-fever214Rabies212Avian Influenza209Verocytotoxigenic *Escherichia coli*209Liver fluke202*Chlamydophila abortus*197Nematodes193Porcine circo virus type 2183Bovine viral diarrhoea virus183Bovine spongiform encephalopathy180Small ruminant mastitis179Varroa mite177*Staphylococcus aureus* mastitis175Theileria174*Mycoplasma bovis*173Echinococcosis167Swine influenza virus162Congo crimean haemorrhagic fever162Swine *Actinobacillus pleuropneumonia*159Bovine respiratory syncytial virus153Parapox152Swine mycoplasma143Cysticercosis130Swine vesicular disease118West Nile Virus118Bovine herpes virus type 1107Porcine reproductive and respiratory syndrome virus107Environmental/Streptococcal mastitis83 Table 5Ranking of 52 infectious diseases of animals by disease category based on the prioritisation model1. Epizootic diseasesScore2. Food producing animal complexesScore3. ZoonosesScorePeste des petits ruminants385Poultry coccidiosis226Nipah virus464African swine fever373Paratuberculosis223Bovine tuberculosis359Rift valley fever365Liver fluke202Non tse-tse transmitted animal trypanosomiasis296Foot and mouth disease310Nematodes193Cryptosporidiosis291African horse sickness294Porcine circo virus type 2183Salmonellosis282Contagious bovine pleuropneumonia269Bovine viral diarrhoea virus183Leishmaniosis262Classical swine fever247Small ruminant mastitis179Brucellosis254Lumpy skin disease244Varroa mite177Leptospirosis250Bluetongue241*Staphylococcus aureus* mastitis175Hepatitis E virus237Orthopox237Theileria174Anthrax220Sheep and goat pox virus218*Mycoplasma bovis*173Campylobacter219Avian Influenza209Swine influenza virus162Q-fever214Parapox152Swine *Actinobacillus pleuropneumonia*159Rabies212Swine vesicular disease118Bovine respiratory syncytial virus153Verocytotoxigenic *Escherichia coli*209West Nile Virus118Swine mycoplasma143*Chlamydophila abortus*197Bovine herpes virus type 1107Bovine spongiform encephalopathy180Porcine reproductive and respiratory syndrome virus107Echinococcosis167Environmental/Streptococcal mastitis83Congo crimean haemorrhagic fever162Cysticercosis130 Table 6Scores from the gap analysis model for the top-10 ranked diseases within each disease category^a^DiseaseDiagnosticsVaccinesPharmaceuticals1. Epizootic diseases Peste des petits ruminants−5−10**20** African swine fever−50**4040** Rift valley fever**291840** Foot and mouth disease−32−20**40** African horse sickness−18**2010** Contagious bovine pleuro pneumonia**93025** Classical swine fever−23−50**40** Lumpy skin disease**27**−5**40** Bluetongue−27−15**40** Orthopox**184015**2. Food producing animal complexes Coccidiosis**95**−35 Paratuberculosis00**40** Liver fluke−9**40**−25 Nematodes−5**40**−65 Bovine viral diarrhoea virus−27−10**40** Porcine circo virus type 2**20**−40**40** Small ruminant mastitis−23−5−50 Varroa mite**4040**−10  *Staphylococcus aureus* mastitis**14**0−30 Theileria**2740**−303. Zoonotic diseases Nipah virus000 Bovine tuberculosis−18**1040** Non tse-tse transmitted trypanosomiasis**324015** Cryptosporidiosis0**40**−45 Salmonellosis−23−30−35 Leishmaniosis−14**35**−20 Brucellosis−5**2040** Leptospirosis−5**5**−60 Hepatitis E virus−32**4040** Anthrax**365**−45Positive scores (indicating a gap) were highlighted in bold^a^Decimals were rounded to the first integer. This may cause apparent deviations between the sum of the individual and the total score

Discussion {#Sec15}
==========

The aim of the DISCONTOOLS project was to build a prioritisation model and gap analysis on control tools as a means of prioritising research on infectious animal diseases with the support of stakeholders via a very open consultation process in the animal health research community.

The major achievement of this project consists of the wide and standardized consultation of the animal health research community, involving a total of 342 animal health scientists from all over the world. The establishment of expert groups was an important step in itself because it brought together scientists from different backgrounds and expertise often leading to lively debate, the challenge of assumptions and the identification of research gaps within their field. Where expert groups could not reach consensus, this was recorded in the D&P under the "Gap" section because it represents a gap in knowledge that needs to be filled by research.

An example is the benefit of bees to pollination. At the outset of the discussion, it was suggested by some of the participants that crop yields could decline by 65% without bees. However, when it was pointed out that wild insects have a more important role in pollination than honey bees, major crop species such as cereals are self-pollinating and many others are wind pollinated \[[@CR27]\], it was agreed that the impact would be considerably less and it was noted that work needs to be done in this area to determine the real impact. Having had this discussion, it was recognised that efforts should be made to control *Varroa* mite as the bee sector -- with its various products -- is valuable (roughly estimated in the consortium at €640 million per annum) and needs to be protected.

As was done in Table [3](#Tab3){ref-type="table"}, it is possible to rank diseases by total scores of the prioritisation model. The total score is valuable in highlighting the overall importance of some diseases. Nipah virus obtained the highest score. This was an interesting outcome and its high ranking is confirmed in other recent studies to prioritize diseases of food-producing animals and zoonoses \[[@CR25], [@CR28]\]. In the case of FMD, it scores highly due to knowledge gaps along with its impact on animal health and welfare, society and trade even though we have good diagnostics and vaccines. Given the impact of the disease, we need heat stable multi-valent vaccines and need to focus research in this area.

It might be surprising that the overall total for FMD (310) in the prioritisation model is lower than that for ASF (373) but an examination of the score in each of the six separate categories (Table [2](#Tab2){ref-type="table"}) which make up the prioritisation model it is apparent where the variation exists. In the case of ASF the score is higher for the impact on international trade, animal health and welfare and significantly higher for control tools where there is no vaccine and diagnostic tests need to be improved.

Despite the maximally standardized consultation rounds and the use of a validation system in the form of Work Packages 2 and 3 and the PMB, the final ranking of diseases should be interpreted with caution. The total scores also hide specific research needs within a disease. In the case of nematodes for example, the total score hides the pressing need to assign resources to the development of vaccines in this area \[[@CR29]\]. To avoid the user missing key data, the "Interpretation of the Scores Guide" was developed as well as the two page summary for each disease. The latter is of particular assistance to the non-specialist user who wants an overview of the critical research needs. Depending on the aim of the research, it may be more informative to compare specific criteria only between diseases (e.g. disease knowledge, impact on wider society, etc.). Two critical factors that can affect the results are: (i) the choice of the weighting coefficients and (ii) the different composition of each expert group. The different criteria of the prioritisation model such as disease knowledge, impact on animal health and welfare, etc. received an equal weight. However, depending on the user, different weight attributions may be desirable. Recently, novel methods have been developed to identify criteria important to different stakeholders by using the nominal group technique and attribute relative weights to the criteria using a wide consultation of different stakeholders and conjoint analysis \[[@CR26]\]. This can result in different rankings according to the criteria and weights defined by different stakeholders (e.g. the public vs. health professionals) and provide additional insights to the decision maker on the spending of research funds \[[@CR19]\]. In contrast to other prioritisation studies where all diseases were scored by the same expert panel, e.g. \[[@CR13], [@CR28]\], in the DISCONTOOLS project, each disease was scored by a different expert panel. This may have introduced bias due to inter-personal differences in scoring, but was considered necessary in order to adequately capture the current status of knowledge and gaps for control tools for each disease.

The epidemiological situation of infectious animal diseases can change rapidly (e.g. the current epidemic of the new porcine epidemic diarrhoea virus \[[@CR30]\]), and biotechnological developments constantly change the landscape of diagnostics, vaccines and pharmaceuticals. As a consequence, the prioritisation exercise should be repeated regularly \[[@CR28]\]. To this end, the database has been placed on a public website with the possibility that the public and research community can provide comments. This was deliberately done to provide an environment where the information in the D&P and the scores could be challenged. The idea is to gather comments over time and then ask the expert group to consider comments made and adjust the information and scoring on the site as appropriate. It is foreseen that the diseases will be systematically reviewed by the expert groups over a 5-year cycle, taking on board the latest technical advances. In fact, this process has already commenced and updated information on the site is available for African swine fever, Foot and mouth disease, Nematodes and Verocytotoxigenic *E. coli*.

Conclusion {#Sec16}
==========

A database was established with the intention of identifying and prioritising research needs in the control of infectious animal diseases in the EU. If the focus of research is now placed on the priorities identified, it will hasten the development of diagnostics, vaccines and pharmaceuticals and reduce the 20% loss in production potential, valued at €28 billion per year in the EU. Funders of research including the European Commission, member states, foundations, trusts along with private industry should use the database to prioritise and focus future research. This will deliver benefits in terms of animal health and welfare but also public health, societal benefits and a safe and secure food supply. The employed method and results should not be considered fixed, but by refining the scoring methodology, challenging and updating the available information on a regular basis and incorporating new diseases, the DISCONTOOLS database has the potential to become a reference point used by stakeholders when prioritising research.

D&P

:   Disease and Product analysis document

ETPGAH

:   European Technology Platform for Global Animal Health

EU
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We wish to thank all Expert Group leaders and members of Expert Groups and stakeholders for their invaluable contribution to the success of the DISCONTOOLS Project.

Funding {#FPar1}
=======

This project was funded by the 7th framework programme of the EU (grant agreement number 211316) and currently receives funding from different research funding bodies from EU member states.

Availability of data and materials {#FPar2}
==================================

The database generated during this project is publicly available on [www.discontools.eu](http://www.discontools.eu/).

Authors' contributions {#FPar3}
======================

DOB conceived the study, coordinated the project and supervised the manuscript. JS assisted in project management, wrote the manuscript and the disease summaries. JC wrote the manuscript and manages the database from 2014. MD managed the project and maintained the database from 2008 to 2013. All authors read and approved the final manuscript.

Authors' information {#FPar4}
====================

DOB was the coordinator of the project under the 7th framework programme on behalf of IFAH-Europe but is currently no longer employed by this organisation. JC is the current project manager commissioned by IFAH-Europe.

Competing interests {#FPar5}
===================

Being a stakeholder driven project, all those involved in the chain from research to commercialisation of products including universities, regulators, farming and veterinary representative organisations along with the pharmaceutical industry contributed to the outcome of this study. The authors declare that they have no financial or personal relationships with other people or organisations that could have inappropriately influenced the present study and manuscript.

Consent for publication {#FPar6}
=======================

Name of disease experts are published below the disease information where written consent has been given. Experts retain the right to access, change or remove their personal data.

Ethics approval and consent to participate {#FPar7}
==========================================

Not applicable.
